An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults

NCT00615836 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

554

Enrollment

INDUSTRY

Sponsor class

Conditions

Nocturia

Interventions

DRUG: Desmopressin Melt

Sponsor

Ferring Pharmaceuticals